Natoli Scientific takes pride in its comprehensive USP<1062> Tablet Compression Characterization services, tailored to address the complexities of tableting in pharmaceutical manufacturing. Staying true to the parameters outlined in the United States Pharmacopeia (USP) Chapter 1062, our approach meticulously evaluates tablet compression behaviors. By thoroughly characterizing the compression profile, we can pinpoint the optimal compression force required to form a cohesive tablet without applying undue stress that could lead to capping — the separation of tablet tops during or after the compression phase.
Our skilled analysts employ state-of-the-art technologies to simulate and scrutinize the tablet formation process under a myriad of conditions, which mirrors the variances that occur in a real-world production scenario. This rigorous testing identifies capping and other defects, such as lamination or sticking, ensuring adjustments can be made pre-emptively. The result is a robust formula and tablet design that mitigates the risk of manufacturing errors, underscores patient safety, and upholds the integrity of the final pharmaceutical product. With a focus on delivering insightful data and comprehensive support, Natoli Scientific’s USP<1062> Tablet Compression Characterization is an invaluable step toward achieving seamless, efficient production and market success.
Natoli NP-RD10A and Natoli AIM™ Pro
Quickly & Easily – with only a small amount of material – establish your USP<1062> data
The Natoli NP-RD10A plays a crucial role in our USP<1062> Tablet Compression Characterization procedures. This sophisticated research and development press is engineered to mimic large-scale production environments, providing us with precise data about the compaction characteristics of tablet formulations. With its robust feature set, including the ability to adjust compression parameters and measure detailed force displacement profiles, the NP-RD10A assists our analysts in identifying the optimal compaction parameters that achieve the perfect balance between tablet hardness, friability, and dissolution rates.
The insights yielded by the NP-RD10A and Natoli AIM™ Pro data acquisition and analytical software during this characterization process are vital for our clients, as it ensures that their tablets will not only be produced efficiently at scale but will also meet the stringent quality standards demanded by regulatory authorities and the pharmaceutical industry.